| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...876450D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0076450 |
| P932 | PMC publication ID | 3792981 |
| P698 | PubMed publication ID | 24116110 |
| P5875 | ResearchGate publication ID | 257650019 |
| P2093 | author name string | Chao Chen | |
| Jingjing Deng | |||
| Zailong Cai | |||
| Jianming Zheng | |||
| Miaoxia He | |||
| Lizao Chen | |||
| P2860 | cites work | p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice. | Q50555695 |
| Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. | Q54392904 | ||
| Low frequency of HER2 amplification and overexpression in early onset gastric cancer. | Q54605374 | ||
| Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms | Q73670302 | ||
| Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes | Q84557762 | ||
| Genetic and epigenetic alterations in pancreatic carcinogenesis | Q24598655 | ||
| Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer | Q28261558 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
| MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| miRNAs, cancer, and stem cell division | Q29618925 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival | Q33748264 | ||
| MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. | Q34127548 | ||
| Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration | Q34229869 | ||
| Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma | Q35123631 | ||
| MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications | Q35588328 | ||
| Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells | Q36157197 | ||
| MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. | Q37907730 | ||
| Repressing the repressor: a new mode of MYC action in lymphomagenesis | Q39886881 | ||
| Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program | Q40251202 | ||
| Cancer statistics, 2003. | Q43729872 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | e76450 | |
| P577 | publication date | 2013-10-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival | |
| P478 | volume | 8 |
| Q89777029 | An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth |
| Q94528741 | Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells |
| Q35853818 | Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir |
| Q91650451 | Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis |
| Q35625038 | High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression |
| Q37715835 | Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q55050306 | MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin. |
| Q38750019 | MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q90312107 | MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential |
| Q38850617 | MicroRNA in pancreatic cancer |
| Q24564267 | Novel therapeutic targets for pancreatic cancer |
| Q30491447 | Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer |
| Q42700661 | Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature |
| Q38812898 | Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery |
| Q98386355 | Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study |
| Q40283637 | The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q41684266 | Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer |
| Q42267634 | miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3. |
| Q55603396 | miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7. |
| Q37564535 | miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q63561056 | miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription |
| Q38733945 | p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium |
Search more.